Pheon Therapeutics
Boston, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $68M
Overview
Engineering novel Antibody-Drug Conjugates for targeted cancer therapy.
Oncology
Technology Platform
Proprietary platform for designing novel Antibody-Drug Conjugates with optimized targeting, linkers, and cytotoxic payloads.
Funding History
1Total raised:$68M
Series A$68M
Opportunities
Growing oncology market and strong pharma appetite for partnering on novel ADC platforms.
Risk Factors
High technical complexity and potential for unforeseen toxicities despite targeted design.
Competitive Landscape
Competes in the crowded but rapidly innovating ADC sector, requiring differentiation in target or payload technology.